New cancer drug targets key growth protein in advanced tumors
Disease control
Terminated
This was an early-stage study to test the safety and find the right dose of a new drug called WBC100. It involved 68 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to see how much of the drug patients could tolerate and to …
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC